Profile data is unavailable for this security.
About the company
DSwiss, Inc. is a biotech-nutraceutical company, which is focused on supplying health and beauty products, including beverages to assist in weight management, and anti-aging creams. Its products include DSwiss Coffee, DSwiss Kiwi, DSwiss Triple SC, DSwiss Silk Mask, DSwiss Coffee Slimming Scrub, DSwiss Peppermint Slimming Gel, DSwiss New Age Essence, DSwiss Enlighten Essence (EE) Cream, SuiSu Hand Purifier and Sanitiser, SuiSu Air Sanitiser, SkinEra, DSwiss BioSpec, Genmune-Pro, and SensiBath. It provides medical consumables, which includes Surgical Gowns, 3-ply Face Masks, N95 Masks, Surgical Gloves, Protective Goggles, Body Infrared Thermometer, and Disposable Bedsheet and Stretcher Cover. Its Original Equipment Manufacturer and Original Design Manufacturer services products include Yumeka Hair Shampoo and Conditioner, MasterLiv, MasterHeart, WellG, and DNA Microarray Genotyping. It supplies its products in Malaysia, Singapore, Thailand, Indonesia, Hong Kong, and China.
- Revenue in USD (TTM)2.60m
- Net income in USD133.59k
- Incorporated2015
- Employees9.00
- LocationDswiss Inc59200 Kuala LumpurPETALING JAYA 59200MalaysiaMYS
- Phone+60 327704032
- Websitehttp://dswissbeauty.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | 6.69m | -64.12m | 57.46m | 30.00 | -- | 1.03 | -- | 8.59 | -21.55 | -21.55 | 2.07 | 0.2766 | 0.1572 | 4.20 | 4.11 | 222,933.30 | -150.67 | -78.25 | -286.92 | -97.00 | -81.97 | -- | -958.69 | -3,988.37 | 0.5604 | -17.65 | 0.787 | -- | 447.53 | -- | -44.44 | -- | 54.06 | -- |
| ImmunoCellular Therapeutics Ltd | 0.00 | -4.93m | 57.77m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Correlate Infrastructure Partners Inc | 403.55k | -2.68m | 57.98m | 11.00 | -- | -- | -- | 143.68 | -0.0825 | -0.0825 | 0.007 | -0.0132 | 0.2844 | -- | -- | -- | -188.66 | -65.78 | -- | -- | 20.26 | 31.50 | -663.41 | -195.16 | 0.3337 | -2.29 | 1.82 | -- | -42.33 | -40.12 | 51.05 | -- | -- | -- |
| Mystic Holdings Inc | -100.00bn | -100.00bn | 59.10m | 79.00 | -- | 2.37 | -- | -- | -- | -- | -- | 0.2155 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2228 | -- | 0.1849 | -- | 199.82 | -- | 34.32 | -- | -- | -- |
| Gemini Therapeutics Inc | 0.00 | -58.70m | 59.24m | 31.00 | -- | 0.5542 | -- | -- | -1.36 | -1.36 | 0.00 | 2.47 | 0.00 | -- | -- | 0.00 | -41.08 | -- | -43.83 | -- | -- | -- | -- | -- | -- | -418.40 | 0.0265 | -- | -- | -- | -8,745.42 | -- | -- | -- |
| Atreca Inc | 0.00 | -109.63m | 59.43m | 105.00 | -- | 0.5159 | -- | -- | -2.91 | -2.91 | 0.00 | 2.99 | 0.00 | -- | -- | 0.00 | -50.79 | -- | -54.29 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.63 | -- | -- | -- |
| Aquestive Therapeutics Inc | 49.90m | -73.02m | 59.75m | 157.00 | -- | -- | -- | 1.20 | -1.76 | -1.76 | 1.20 | -1.81 | 0.8102 | 4.39 | 3.19 | 317,834.40 | -118.56 | -81.64 | -207.11 | -120.77 | 65.49 | 68.58 | -146.34 | -92.68 | 1.30 | -2.47 | -- | -- | 10.87 | -0.3708 | -26.45 | -- | -1.33 | -- |
| Surface Oncology Inc | 30.55m | -62.96m | 60.36m | 67.00 | -- | 0.4582 | -- | 1.98 | -1.29 | -1.29 | 0.6229 | 2.27 | 0.1529 | -- | -- | 455,925.40 | -31.52 | -16.81 | -34.87 | -19.57 | -- | -- | -206.10 | -58.17 | -- | -24.06 | 0.1676 | -- | -97.87 | -16.53 | -232.27 | -- | -32.17 | -- |
| DSwiss Inc | 2.60m | 133.59k | 60.60m | 9.00 | 450.62 | 685.16 | 297.64 | 23.33 | 0.0007 | 0.0007 | 0.0126 | 0.0004 | 6.72 | 118.52 | 58.74 | 288,663.30 | 40.38 | -31.31 | 300.35 | -85.67 | 20.78 | 28.77 | 6.01 | -19.45 | 0.9745 | 34.60 | 0.4281 | -- | 45.33 | 70.19 | 1,550.39 | -- | 2.46 | -- |
| ImmuCell Corporation | 20.46m | 273.41k | 60.81m | 64.00 | 227.14 | 1.86 | 22.16 | 2.97 | 0.0346 | 0.0346 | 2.63 | 4.23 | 0.456 | 3.04 | 11.81 | 340,917.70 | 0.6095 | -2.74 | 0.642 | -2.93 | 47.86 | 46.86 | 1.34 | -7.11 | 5.07 | 2.14 | 0.2461 | -- | 25.43 | 15.06 | 92.34 | -- | -6.17 | -- |
| Flora Growth Corp | 21.78m | -48.76m | 61.18m | 162.00 | -- | 0.9746 | -- | 2.81 | -0.781 | -0.781 | 0.3603 | 0.8158 | 0.3984 | 2.71 | 9.63 | -- | -89.53 | -- | -102.64 | -- | 36.01 | -- | -224.71 | -- | 2.09 | -7.17 | 0.056 | -- | 8,371.70 | -- | -49.96 | -- | -- | -- |
| X4 Pharmaceuticals Inc | 0.00 | -101.52m | 61.21m | 100.00 | -- | 0.9189 | -- | -- | -3.31 | -3.31 | 0.00 | 0.9704 | 0.00 | -- | -- | 0.00 | -84.03 | -60.56 | -99.77 | -67.97 | -- | -- | -- | -4,315.88 | -- | -22.78 | 0.5239 | -- | -100.00 | -- | -65.20 | -- | 53.15 | -- |
| Longboard Pharmaceuticals Inc | 0.00 | -36.12m | 61.63m | 21.00 | -- | 0.7403 | -- | -- | -2.12 | -2.12 | 0.00 | 4.84 | 0.00 | -- | -- | 0.00 | -34.20 | -- | -36.05 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -93.03 | -- | -- | -- |
| Pyxis Oncology Inc | 0.00 | -87.95m | 63.04m | 67.00 | -- | 0.2942 | -- | -- | -2.74 | -2.74 | 0.00 | 6.53 | 0.00 | -- | -- | 0.00 | -45.15 | -- | -48.02 | -- | -- | -- | -- | -- | -- | -30.59 | 0.00 | -- | -- | -- | -492.26 | -- | -- | -- |
